The article News You Might Have Missed: Oct 27th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Eleusis’ IV form of psilocin will see clinical trials, but Eleusis-backed research into the anti-inflammatory properties of psychedelics is uncertain....
The article Atai Completes Enrollment of Phase 2a Trial for Depression was originally published on Microdose. atai Life Sciences has moved its most advanced...
The article A Deeper Look at Atai Life Sciences’ R&D Day was originally published on Microdose. Today, atai Life Sciences (Nasdaq: ATAI) held its...
Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing...
More groups are researching the effect of psychedelics on TBI. The post Doctors Look to Psychedelics to Address Concussion Crisis appeared first on Green...
The article Beckley Psytech Acquires Eleusis Therapeutics was originally published on Microdose. Beckley Psytech Strengthens Pipeline and Development...
Privately-owned psychedelic medicine company Beckley Psytech Limited is buying Eleusis Therapeutics Limited in an all-stock transaction. By acquiring Eleusis,...
Psychedelic medicines company Beckley Psytech has reached an agreement to acquire its rival Eleusis Therapeutics, in alignment with The post Consolidation...
Galan more than doubles Hombre West’s resources to 5.8Mt of contained lithium carbonate equivalent Green Technology Metals secures 100% ownership ......